For sales

📢 Highlights from March 16 to 23 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma GRIN Therapeutics (FDA, Orphan) The FDA Grants Orphan Drug Designation to GRIN Therapeutics' Radiprodil for Treating GRIN-Related Neurodevelopmental Disorder BioArctic (FDA, Orphan) The FDA Grants Orphan Drug Designation to BioArctic's Exidavnemab for Treating Multiple System Atrophy Johnson & Johnson (FDA, Approval) J&J's TREMFYA (Guselkumab) Receives FDA Approval for Adults With Moderately to Severely Active Crohn's Disease Henlius (FDA, Orphan) The FDA granted Orphan Drug Designation to Henilu's Anti-HER2 mAb HLX22 for the Treatment of Gastric Cancer Anuncia Medical (FDA) Anuncia Medical Received FDA Breakthrough Device Designation for ReFlow EVD, a Device for External Ventricular Drains to Manage Brain Swelling and Elevated Intracranial Pressure All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.